Sartorius (SRT3) Given a €86.00 Price Target at HSBC

HSBC set a €86.00 ($106.17) price target on Sartorius (FRA:SRT3) in a report issued on Wednesday. The firm currently has a neutral rating on the stock.

A number of other analysts have also recently issued reports on the company. Kepler Capital Markets set a €78.00 ($96.30) target price on Sartorius and gave the stock a neutral rating in a report on Wednesday, January 31st. Berenberg Bank set a €85.00 ($104.94) target price on Sartorius and gave the stock a buy rating in a report on Tuesday, October 17th. Commerzbank set a €76.00 ($93.83) target price on Sartorius and gave the stock a neutral rating in a report on Wednesday, October 25th. Nord/LB set a €70.00 ($86.42) target price on Sartorius and gave the stock a sell rating in a report on Tuesday, October 17th. Finally, Deutsche Bank set a €80.00 ($98.77) target price on Sartorius and gave the stock a neutral rating in a report on Friday, December 1st. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. Sartorius presently has an average rating of Hold and a consensus target price of €79.55 ($98.20).

Shares of Sartorius (FRA:SRT3) opened at €97.65 ($120.56) on Wednesday. The company has a market capitalization of $7,060.00 and a PE ratio of 79.39. Sartorius has a fifty-two week low of €64.20 ($79.26) and a fifty-two week high of €100.00 ($123.46).

ILLEGAL ACTIVITY NOTICE: “Sartorius (SRT3) Given a €86.00 Price Target at HSBC” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/08/sartorius-srt3-given-a-86-00-price-target-at-hsbc.html.

Sartorius Company Profile

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply